Only Canada and the U.S. measure drug shortages, but not in the same manner. The EU and U.K. are slowly coming around. More collaboration is needed, writes Jacalyn M. Duffin. Photograph courtesy of Pixabay
From an accounting, budgeting, and reporting perspective, government investments in intangible assets, like early treatment programs, bear little distinction from spending on paper clips. And that's a problem.
National standards, digital modernization, and national licensure would give us a way to improve Canada’s leadership role in global health-care and build an improved and more national health-care system domestically.
The Trudeau government’s actions in health policy have demonstrated a return to a more interventionist stance by the federal government, one that involves a more deliberate steering of provincial health and social services delivery through spending and performance assessment.
With a focus on outcomes rather than outputs, spending on health care can be linked to outcomes that matter to patients, rather than to the volumes of services, processes, or products that may or may not achieve those outcomes.